The Ticker

Pfizer sells Cambridge office/lab building

Waltham's King Street Properties, a private real estate investment management firm that focuses on science-based property, has purchased 87 Cambridge Park Drive for $14.8 million, according to documents filed with the Southern Middlesex County Registry of Deeds.

The Cambridge office and lab-space building is among several that Pfizer Inc. is selling as part of its consolidation of area employees into a new Kendall Square research and development facility that opened this month.

Mass. biotechs collaborating with
foreign firms to get state grants

The Massachusetts Life Sciences Center has launched a new "universal partnerships" program to give grant funding to Massachusetts companies in research and development collaborations with life science organizations outside the United States, including other companies, academic institutions, hospitals or research institutes. First-year grants will range from $50,000 to $200,000 for eligible "milestone" projects. Gov. Deval Patrick made the announcement at the BIO International Convention in San Diego yesterday.

Staples to price-match Amazon.com

Framingham office supplies chain Staples Inc. is getting a jump on the back-to-school shopping season with a new price-match guarantee. Starting Sunday, it will price-match items sold and shipped by Amazon.com or any retailer who sells products in both retail stores and online under the same brand. Customers also will get an additional 10 percent off the difference between the Staples price and the competitor's price.

Today

•  Commerce Department releases first-quarter gross domestic product.
•  Commerce Department releases durable goods for May.

TOMORROW

•  Labor Department releases weekly jobless claims.
•  Commerce Department releases personal income and spending for May.
•  Freddie Mac releases weekly mortgage rates.
•  Katrine Bosley, left, has joined Cambridge-based Editas Medicine as its chief executive officer. Bosley brings to Editas more than 20 years of experience in the biotechnology industry.

Prior to joining Editas, Bosley was CEO of Avila Therapeutics, which was acquired by Celgene in 2012, and most recently spent time at the Broad Institute as an entrepreneur-in-residence.

Anda sedang membaca artikel tentang

The Ticker

Dengan url

http://bintanggugel.blogspot.com/2014/06/the-ticker_25.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

The Ticker

namun jangan lupa untuk meletakkan link

The Ticker

sebagai sumbernya